Chu Yu-Waye

Chief Medical Officer at CTMX; Officer at FATE

Sold, on record
$1.2M
Dollars the filings state
Form 4 sales
8
Latest Mar 17, 2026
Form 144 notices
1
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • CTMXCytomX Therapeutics, Inc.Chief Medical Officer
  • FATEFATE THERAPEUTICS INCOfficer

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale FATEPlan not stated
    Dec 10, 2021 2021

    Sold 7,500 shares at $51.46 ($386k)

    Chu Yu-Waye, Senior VP Clinical Development

    Sold 5.6% of holdings ($6.9M position)125,758 shares leftFiling

  2. 2 Form 4 sale FATEPlan not stated
    Jan 11, 2022 +32 days

    Sold 3,965 shares at $48.51 ($192k)

    Chu Yu-Waye, Senior VP Clinical Development

    Sold 3.2% of holdings ($6.1M position)121,793 shares leftFiling

  3. 3 Form 4 sale FATEPlan not stated
    Apr 19, 2022 +98 days

    Sold 4,062 shares at $35.37 ($144k)

    Chu Yu-Waye, Chief Medical Officer

    Sold 2.6% of holdings ($5.5M position)151,033 shares left1x usual sizeFiling

  4. 4 Form 4 sale FATEPlan not stated
    Jan 10, 2023 +266 days

    Sold 7,825 shares at $5.24 ($41k)

    Chu Yu-Waye, Chief Medical Officer

    Sold 5.2% of holdings ($791k position)143,208 shares left1.9x usual sizeFiling

  5. 5 Form 144 notice FATENotice
    Apr 18, 2023 +98 days

    Filed to sell 2,532 shares ($17k)

    Chu Yu-Waye, Officer

    No 10b5-1 plan0.4x usual sizeFiling

  6. 6 Form 4 sale FATERoutine
    Apr 18, 2023 same day

    Sold 2,532 shares at $6.57 ($17k)

    Chu Yu-Waye, Chief Medical Officer

    10b5-1 planSold 1.8% of holdings ($942k position)140,676 shares left0.4x usual sizeFollows a Form 144Filing

  7. 7 Form 4 sale CTMXNo plan
    Mar 18, 2025 +700 days

    Sold 4,025 shares at $0.60 ($2k)

    Chu Yu-Waye, Chief Medical Officer

    No 10b5-1 planSold 2.9% of holdings ($84k position)135,725 shares leftFirst sale on recordFiling

  8. 8 Form 4 sale CTMXNo plan
    Mar 17, 2026 +364 days

    Sold 21,279 shares at $6.42 ($137k)

    Chu Yu-Waye, Chief Medical Officer

    No 10b5-1 planSold 10.1% of holdings ($1.4M position)189,446 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (9)

Form 144 notices and Form 4 sales by Chu Yu-Waye
Source
Mar 17, 2026Mar 19, 2026CTMXChief Medical OfficerForm 4 sale21,279$137k10.1%No planSEC
Mar 18, 2025Mar 20, 2025CTMXChief Medical OfficerForm 4 sale4,025$2k2.9%No planSEC
Apr 18, 2023Apr 19, 2023FATEChief Medical OfficerForm 4 sale2,532$17k1.8%RoutineSEC
Apr 18, 2023Apr 18, 2023FATEOfficerForm 144 notice2,532$17kNoticeSEC
Jan 10, 2023Jan 11, 2023FATEChief Medical OfficerForm 4 sale7,825$41k5.2%Plan not statedSEC
Apr 19, 2022Apr 21, 2022FATEChief Medical OfficerForm 4 sale4,062$144k2.6%Plan not statedSEC
Jan 11, 2022Jan 13, 2022FATESenior VP Clinical DevelopmentForm 4 sale3,965$192k3.2%Plan not statedSEC
Dec 10, 2021Dec 13, 2021FATESenior VP Clinical DevelopmentForm 4 sale7,500$386k5.6%Plan not statedSEC
Apr 16, 2021Apr 20, 2021FATESenior VP Clinical DevelopmentForm 4 sale3,275$273k4.8%Plan not statedSEC